Biotech entity
fda-approval is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Department of the Interior, the most common co-covered peer. The tracked stories average 3 original sources each. Earthjustice appears in 1 tracked Biotech story from July 20, 2026.
Last mentioned: Jul 20, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
fda-approval is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Department of the Interior, the most common co-covered peer. The tracked stories average 3 original sources each. Earthjustice appears in 1 tracked Biotech story from July 20, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 5 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Earthjustice. Shared-story counts are live from our verified record — not editorial picks.
The Trump administration’s rollback of Endangered Species Act protections could accelerate habitat loss for over 1,600 listed species, raising concerns in the biotech sector about the loss of undiscovered natural compounds critical for drug development.
Source: redmond-reporter.com · bothell-reporter.com
Earthjustice is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
